The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer

Simon Gebremeskel, Terry Levatte, Robert S. Liwski, Brent Johnston, Michael Bezuhly

Research output: Contribution to journalArticlepeer-review

99 Citations (Scopus)
Original languageEnglish
Pages (from-to)234-240
Number of pages7
JournalInternational Journal of Cancer
Volume136
Issue number1
DOIs
Publication statusPublished - Jan 1 2015

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • ADP receptor
  • P2Y12
  • breast cancer
  • endothelium
  • melanoma
  • metastasis
  • platelet
  • ticagrelor

Fingerprint

Dive into the research topics of 'The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer'. Together they form a unique fingerprint.

Cite this